RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Perrigo Company Stock

Perrigo Company Stocks 2024

Perrigo Company Stocks

135.3 M

Ticker

PRGO

ISIN

IE00BGH1M568

WKN

A1XAEY

In 2024, Perrigo Company had 135.3 M outstanding stocks, a 0% change from the 135.3 M stocks in the previous year.

The Perrigo Company Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2028e135.3
2027e135.3
2026e135.3
2025e135.3
2024e135.3
2023135.3
2022134.5
2021133.6
2020136.1
2019136.5
2018138.3
2017142.6
2016143.3
2015139.8
2014115.6
201394.5
201294.1
201193.5
201092.8
200993.6
200895.2
200793.8
200694.1
200577.3
200472.3

Perrigo Company shares outstanding

The number of shares was Perrigo Company in 2023 — This indicates how many shares 135.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Perrigo Company earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Perrigo Company's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Perrigo Company’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Perrigo Company's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Perrigo Company Aktienanalyse

What does Perrigo Company do?

The Perrigo Company PLC is a globally operating company in the pharmaceutical and healthcare products sector. The company was founded in 1887 as The Donerail Corporation and is headquartered in Dublin, Ireland. Perrigo's business model focuses on healthcare products and offers a wide range of products, ranging from over-the-counter medications to dietary supplements and personal care products. The company is divided into three business segments: Consumer Healthcare Americas, serving the markets in North, Central, and South America; Consumer Healthcare International, serving the markets in Europe, Australasia, Asia, and Israel; and Pharmaceutical, which includes pharmaceutical manufacturing and development. The Consumer Healthcare Americas segment focuses on developing products that aid in the treatment and prevention of various health issues. Some of the well-known products include the dietary supplement brand Emergen-C, the allergy and sinus product brand GoodSense, and the pain relief brand TopCare. Consumer Healthcare International offers similar products to the Consumer Healthcare Americas segment, but with a focus on the international market. The product range includes pain relief, cold and flu products, skincare products, vitamins and minerals, oral care products, and household products. The Pharmaceutical segment specializes in the manufacturing and development of generic drugs, biosimilars, and over-the-counter medications. The company has extensive experience in generics manufacturing and has recently expanded its product portfolio to include biologics and pharmaceutical development. Perrigo's pharmaceutical products are widely recognized and sold in many countries. Some of the well-known products include the blockbuster injectable methotrexate Heumann, a highly effective immunosuppressant used in the treatment of autoimmune diseases. Perrigo is a leading provider of quality products and continuously develops new products to meet the needs of its customers. The company places a high value on research and development and works closely with professionals in the medical field. Perrigo has established an extensive global distribution network to ensure its products are available worldwide. In recent years, the company has strengthened its market presence through mergers and acquisitions. In 2015, Perrigo acquired Irish pharmaceutical company Elan Corporation, which specializes in the development of drugs for neurodegenerative diseases. This acquisition expanded Perrigo's product portfolio in biologics development. Since 2019, Ranir, a global leader in oral care products, has also been integrated into the company. In the recent past, Perrigo has set a target date by which it aims to resolve tax issues related to a series of disputed transactions with the IRS. The target is the end of June 2021, by which the company aims to achieve a satisfactory outcome and move forward. Overall, Perrigo has a successful history as a leading provider of pharmaceutical and healthcare products. The company is able to meet the needs of its customers worldwide by offering a wide range of products, from over-the-counter medications to dietary supplements and personal care products. With a strong focus on research and development, Perrigo has strengthened its market presence through mergers and acquisitions in recent years, promising a bright future for the company. Perrigo Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Perrigo Company's Shares Outstanding

Perrigo Company's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Perrigo Company’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Perrigo Company’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Perrigo Company’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Perrigo Company stock

How many stocks are there of Perrigo Company?

The current number of stocks of Perrigo Company is 135.3 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Perrigo Company are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Perrigo Company evolved in recent years?

The number of shares of Perrigo Company has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Perrigo Company as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Perrigo Company?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Perrigo Company pay?

Over the past 12 months, Perrigo Company paid a dividend of 1.09 USD . This corresponds to a dividend yield of about 3.73 %. For the coming 12 months, Perrigo Company is expected to pay a dividend of 1.08 USD.

What is the dividend yield of Perrigo Company?

The current dividend yield of Perrigo Company is 3.73 %.

When does Perrigo Company pay dividends?

Perrigo Company pays a quarterly dividend. This is distributed in the months of December, April, June, September.

How secure is the dividend of Perrigo Company?

Perrigo Company paid dividends every year for the past 25 years.

What is the dividend of Perrigo Company?

For the upcoming 12 months, dividends amounting to 1.08 USD are expected. This corresponds to a dividend yield of 3.71 %.

In which sector is Perrigo Company located?

Perrigo Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Perrigo Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Perrigo Company from 9/17/2024 amounting to 0.276 USD, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did Perrigo Company pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Perrigo Company in the year 2023?

In the year 2023, Perrigo Company distributed 1.04 USD as dividends.

In which currency does Perrigo Company pay out the dividend?

The dividends of Perrigo Company are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Perrigo Company

Our stock analysis for Perrigo Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Perrigo Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.